NEW OPPORTUNITIES PATHOGENETIC THERAPY OF PULMONARY ARTERIAL HYPERTENSION

NEW OPPORTUNITIES PATHOGENETIC THERAPY OF PULMONARY ARTERIAL HYPERTENSION

The review summarizes new data on medical treatment of pulmonary arterial hypertension (PAH). Pulmonary arterial remodeling is known to be the main pathophysiological characteristic, involving cell proliferation, hypertrophy and migration, as well as apoptotic abnormalities and changes in extracellu...

Full description

Saved in:
Bibliographic Details
Main Authors: T. V. Martynuk, S. N. Nakonechnikov, I. E. Chazova
Format: Article
Language:Russian
Published: InterMedservice 2013-03-01
Series:Евразийский Кардиологический Журнал
Subjects:
легочная артериальная гипертензия
эндотелин-1
антагонисты рецепторов эндотелина
оксид азота
ингибиторы фосфодиэстеразы типа 5
простациклин
pulmonary arterial hypertension
endothelin-1
endothelin receptor antagonists
nitric oxide
type 5 phosphodiesterase inhibitors
prostacyclin
Online Access:https://www.heartj.asia/jour/article/view/5535
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.heartj.asia/jour/article/view/5535

Similar Items